chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Chills; Body aches; Headache; Fever (100.8); Temporary cough lasting a few hours; This is a spontaneous report from a non-contactable consumer, the patient. A 28-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 10:00 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any concomitant medications. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20Apr2021 at 23:00, roughly 12 hours after administration, the patient experienced chills, body aches, headache, fever (100.8) and temporary cough lasting a few hours. On 20Apr2021 at 23:00, the patient underwent lab test which included body temperature test and the result was found to be 100.8 (units unspecified). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, body aches, headache, fever (100.8) and temporary cough lasting a few hours were resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
stomach discomfort; dizziness; fever; chills; nausea; sore arm (site of injection); This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (stomach discomfort), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills) and NAUSEA (nausea) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Feb-2021, the patient experienced ABDOMINAL DISCOMFORT (stomach discomfort), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (sore arm (site of injection)). On 08-Feb-2021, ABDOMINAL DISCOMFORT (stomach discomfort), DIZZINESS (dizziness), PYREXIA (fever), CHILLS (chills), NAUSEA (nausea) and VACCINATION SITE PAIN (sore arm (site of injection)) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment details not included. The patient's medical history was not provided. Relevant concomitant products usage were not reported by the reporter.
Left lymph node swelled up to size of orange under left arm. Swelling (3 to 4  inches) round red area round injection site going down arm.
Intense headache, head pain. Joint pain in neck, left elbow and mid to lower back.  Lasted about 18 hours.
Pt starts to itch all over body. Pt took 2 Benadryl tablets prior to vaccine.
Information has been received from a health professional concerning a 3 month old male who on 8/13/01 was vaccinated with Hep-B (batch 3018A3). Concomitant therapy included poliovirus (IPOL) (batch SA8200) and diphtheria toxoid (+) Haemophilus B conjugate vaccine (+) pertussis vaccine (+) tetanus toxoid (batch SAR5992). On 8/14/01 (also reported as 8/13/01), the pt developed a multiforme erythema and swollen hands and eyes. He was hospitalized for 3 days and responded well to treatment with corticosteroids and antihistamines. The physician concluded to 'an allergic reaction secondary to immunization".
I got shingles. I got a mild case. I just had a rash on my right shoulder the back part. I received a topical cream for the rash. I also had my lymph nodes were swollen. I have never had the chicken pox. The pain only lasted days. The swollen of the lymph nodes lasted a few days. The rash lasted a few weeks. My clavicle was swollen after the vaccine and then again when I had shingles.
heart attack; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A 23 year-old patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: MYOCARDIAL INFARCTION (medically significant), outcome "unknown", described as "heart attack".  The lot number for bnt162b2 was not provided and will be requested during follow up.
Severe dizziness and headache, 2 days after injection. Also upset stomach and body aches.
Medication Error: Patient disclosed he received AstraZeneca dose while in the recovery area, after he received the Johnson and Johnson vaccine. Patient educated that there is no current recommendations for booster of AstraZeneca or Johnson and Johnson. After 15 minute recovery, patient advised to monitor for any reactions and to follow up with doctor.
Left arm and hand numbness 15-30 minutes after receiving hepatitis B vaccine left deltoid. Numbness involved ulnar volar aspect of hand and fourth and fifth fingers. Seen by occupational health physician, given script for Celebrex 100mg, daily. Labs ordered were: CBC, metabolic panel, SED rate, thyroid studies (history of hypothyroid). Re-evaluated by physician 48 hours later; no further symptoms.
Left arm tender and warm, chills, body aches,  fever 102-100.7 after Tylenol, joints  pain, lightheadedness and chest burning  with deep breaths
Extremely tired after the first typhoid pill. Remained tired over days pill was taken and 2 days after finishing. No nausea or vomiting. "Could have slept 20 hrs each day". Pills taken correctly started 8-15-2013.
Acute unilateral (left) sensorineural hearing loss - 2 1/2 weeks after first covid 19 vaccine (moderna).  Documented moderate to severe hearing loss left ear by serial auditory testing.  Treated with approx 18 days of oral corticosteroids. hearing recovered by 2/18/21 follow up audiogram and visit.
Pt initially reported feeling tingling sensation of lips and, "eyes feeling tight". Then pt states she had throat tightness. She was given crackers, juice but she said it was difficult to swallow.  Per RN documentation "Pt continued to complain of lips slightly feeling numb and diffuse tingling sensation. IM Benadryl administered at 1840 with improvement, pt reported "numbness improving" and "eyes feeling back to normal".    After further observation, pt c/o difficulty swallowing, rapidly became anxious and reported SOB. EPI pen administered at 1902, supplemental O2 provided with improvement."  Pt brought to the ED by paramedics  Per ED MD   "Upon arrival, patient mildly hypertensive, no stridor, speaking in full sentences, no wheezing, clear lungs bilaterally.  Based on history exam, concern for allergic reaction vaccine"  Tryptase not drawn.Pt discharged in good condition
Patient states started coughing real bad to the point of throwing up. Then she started to feel like her throat was closing up and she could not breathe. At this point her heart was racing and she had to concentrate to breathe. Approx an hour and a half after symptoms started she called the Doctor and proceeded to the Emergency Room.   ER records show dyspnea, swelling of the throat and a generalized macular rash. Prednisone 60mg PO and Benadryl 25mg PO were given at the ER.
Inappropriate administration (drip down arm); dripped down his arm; A spontaneous report was received from a consumer who was a male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and the vaccine was not administered correctly and dripped down his arm.  The patient's medical history was not provided. No concomitant medications were reported.  On an unknown date, prior to the onset of the events, the patient received their first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection. While receiving the vaccine, the patient suspected that the vaccine was not administered correctly and dripped down his arm. No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not provided.  The event, vaccine was not administered correctly and dripped down his arm, was considered resolved on an unknown date.; Reporter's Comments: This case concerns a male patient who received his first of two planned doses of mRNA-1273 intramuscularly for prophylaxis of COVID-19 infection the vaccine was not administered correctly and dripped down his arm. There were no reported adverse events after the vaccine was administered in this case of Incomplete dose administered and exposure via skin contact.
Light headed and dizziness 3 hours after vaccination and lasted a couple hours.  Breathing and heart beating like had just got back from a run the remainder of that day.  Skin tender to the touch (especially in the lower back and legs) started a few hours after the vaccination and is almost gone today 04/28/10.  Had severe headaches the night of the vaccination and the day after vaccination.  Dry cough with a lot of pressure in my head started morning of 04/28/10.  Started a temp of 101.3 the night of the vaccination and temp ot 101.0 the next day.  Having cramps just below the ribcage the day after the vaccination.  Had night sweats the 2nd night after the vaccination.
L shoulder pain - stiffness, chills. Started 11hrs after infection - pt unable to speak or move - lasted 5-10 min - another chill at 12hrs. Later - 13 hrs - ok.
This spontaneous report as received from a registered nurse refers to a 64 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date in 2008, the patient was vaccinated with the first dose of VAQTA exact dose, route of administration, lot # and expiration date were not provided. The reporter stated that the patient had not received the second dose of suspect vaccine, at six to 18 months after the initial dose and wanted to receive the second dose of VAQTA, at the time of report. There were no adverse effects reported. Additional information has been requested.
This spontaneous report as received from the patient's wife refers to a male patient of unknown age who "about two days ago" (06-FEB-2013) was vaccinated with a dose of ZOSTAVAX (dose, route not reported) Product circular: 9989115. No concomitant Medications reported. "About two days ago" (06-FEB-2013), the patient developed high temperature and elevated heart rate after receiving ZOSTAVAX. The outcome of the events was unknown. The relatedness between the events and ZOSTAVAX was unknown. Additional information is not expected.
I awoke on 1/23/2021 (Saturday) morning to find my face and especially my lips swollen.  Contacted doctor's office for the on-call; he strongly suggested I visit the ER. Was kept there for 2-3 hours for observation.  Was considered "hypertensive,"  routine blood work done (CBC, metabolic panel) all of which were normal.  Was given Prednisone and ZyrTec.   After no change in my condition, was discharged with instruction to contact primary physician and continue to take Prednisone and ZyrTec for the next four more days.   The reason for the facial and lip swelling could not be determined......It was indicated that the swelling could be one of several things including an allergic reaction to something topical like a lip balm (I used a Blistix application before bed), a reaction to one of my medication (BP med-Olmesartan, which they told me to discontinue) or less likely a reaction to the COVID vaccine.
Kinrix as 4th dose of Dtap and 3rd of IPV; was suppose to receive flu vaccine and got Kinrix and flu vaccine; This case was reported by a other health professional and described the occurrence of inappropriate schedule of vaccine administered in a patient who received DTPa-IPV (Kinrix) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Concomitant products included INFLUENZA VACCINE.   On an unknown date, the patient received Kinrix and Kinrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device and not applicable after receiving INFLUENZA VACCINE, the patient experienced inappropriate schedule of vaccine administered and wrong vaccine administered. On an unknown date, the outcome of the inappropriate schedule of vaccine administered and wrong vaccine administered were unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2023017376   Additional Information: GSK Receipt Date: 03-FEB-2023 Reporter's Comments: The reporter reported that the patient received Kinrix was 4th dose of Dtap and 3rd dose of IPV. They receive it in error as HCP stated that they had the wrong shot of record. The patient was supposed to receive a flu vaccine only but got Kinrix and Flu vaccine. HCP did not provide information on what flu vaccine the patient received. Additional Supportive Information: The patient received Kinrix was 4th dose of Dtap and 3rd dose of IPV which led to Inappropriate schedule of vaccine administered The patient supposed to receive a flu vaccine only but got Kinrix and Flu vaccine, which led to Wrong vaccine administered. Additional Supportive Information: This case was linked with case US2023017376, reported by the same reporter for same patient.; Sender's Comments:  US-GSK-US2023017376:Same reporter
shingles; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a patient of unknown age and gender. No information was provided regarding medical history, concurrent conditions, or concomitant medications. In 2012, the patient was vaccinated (inoculated) with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) by a pharmacist for long-term prevention of shingles and zoster related conditions (prophylaxis). Subsequently, the patient was treated by a healthcare provider for shingles. As a direct and proximate result of the patient's use of the vaccine live (ZOSTAVAX) vaccine, the patient had and will continue suffer ongoing injuries, including but not limited  to: mental and physical pain and suffering; medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and cost included care for hospitalization, physician care, monitoring, treatment, medications, and supplies: diminished capacity for the enjoyment of life; diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; and other losses and damages; and will continue to suffered such losses, and damages in the future. The outcome of the event shingles was not provided. Therefore, the causality for the event was related to zoster vaccine live (ZOSTAVAX).
patient reports that after getting the first vaccine she had tinnitus in both ears, constant buzzing that has lasted through the second vaccine as well
low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (low grade fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history ).    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In April 2021, the patient experienced PYREXIA (low grade fever). At the time of the report, PYREXIA (low grade fever) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information not provided     Reporter did not allow further contact
Next day after shot, chills and joint pain from 7Am till 6pm.  Lethargic for about week afterwards.  Had first heart palpitations with dizziness approx 1-2 months afterwards and 2nd palpitations felt in May 2021.
Within 5 minutes of receiving the vaccine the patient was in a standing position and suddenly fell to the ground hitting the left side of his forehead.
pt recv vax; fever 105.8 w/in 24 hr of last 2 DTP inject;
I felt drained of energy for two weeks and experienced diarrhea on a daily basis and had mild headaches as well.
Fever 102, chills, body aches, joint pain, fatigue, flu like symptoms, arm pain.
Localized redness, swelling, itching and hemorrhage (bruising). Treated with Benadryl and Motrin.
pt recv vax 25APR97 & felt dizzy, had pt lie down for 10min, feeding fine 3PM;pt fainted in waiting room hitting head;BP 110/80, P60, resp rate 20;3:15 BP 110/78, P60, resp rate 20;sl h/a, dizzy;better p/head injury;
This spontaneous report was received from a pharmacist refers to a 6 unspecified patients of an unknown age and gender. The patient's relevant medical history, concurrent condition and concomitant medication were not reported. On 26-APR-2016, one unspecified patient was vaccinated with an improperly stored dose of PNEUMOVAX 23, lot # M006139 (expiry date: 13-MAY-2017) (dosage not reported). The temperature excursion was -0.5 (unspecified units) for 7 days. No previous excursion was reported. No adverse effect reported. This is one of several reports received from the same reporter. Additional information has been requested.
walking issue appeared; bad muscle aches near his groin; arm became very discolored; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administration date 21Apr2021 (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (Dose: 1), for COVID-19 immunization. The following information was reported: GAIT DISTURBANCE (non-serious) with onset Apr2021, outcome "unknown", described as "walking issue appeared"; MYALGIA (non-serious) with onset Apr2021, outcome "unknown", described as "bad muscle aches near his groin"; SKIN DISCOLOURATION (non-serious) with onset Apr2021, outcome "unknown", described as "arm became very discolored".  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
*States developed multiple joint pain and weakness 8 hours after receiving Pfizer COVID19 second dose vaccine 8/2. The day after had a lot of fatigue, generalized myalgias. The day after that every single joint in her body hurt which made it very hard to ambulate around. Could not lift the covers of her bedsheets to her shoulders because of the pain. Took ibuprofen last night which helped a bit but still having significant joint pain and feels the hands are weak with no strength. NO active swelling noted. *No fevers/chills. NO headaches or vision changes. No sciatica or radiculopathy. No swelling of extremities. No rashes. No SOB, chest pain or palpitations. *On exam afebrile. No synovitis noted. 4/5 motor strength b/l upper ext. with decreased grip strength b/l hands. *Will check further labwork. As nursing will avoid meloxicam and trial oral prednisone and advised to hold breastfeeding until 4 hours after taking prednisone. Close clinical f/u
Pt recvd vax approx mid 1991 & on 13FEB92 devel fever, chills & sweating; next day pt was hospitalized for bacteremia; BC pos for pneumococcus; pt tx PCN & recovered; serology showed type 6B pneumococcus;
Elevating and fluctuating heartbeat; Got an infection that went down her arm; Dizziness; Weakness; Went down to half of the right arm, purple circles after having the rash; Rash; Itch; Pink under the skin; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE IRREGULAR (Elevating and fluctuating heartbeat), VACCINATION SITE INFECTION (Got an infection that went down her arm), DIZZINESS (Dizziness), ASTHENIA (Weakness) and RASH (Went down to half of the right arm, purple circles after having the rash) in an 84-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included ALLOPURINOL, LOVASTATIN, LEVOTHYROXINE, GABAPENTIN, OMEPRAZOLE, ACETYLSALICYLIC ACID (ASPIRIN (E.C.)), PARACETAMOL (TYLENOL), B12, FISH OIL, ASCORBIC ACID, ROSA CANINA FRUIT (VITAMIN C & ROSEHIP), PROBIOTIC 10 and CETIRIZINE HYDROCHLORIDE (ZYRTEC ALLERGY) for an unknown indication.    On 16-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HEART RATE IRREGULAR (Elevating and fluctuating heartbeat), VACCINATION SITE INFECTION (Got an infection that went down her arm), DIZZINESS (Dizziness), ASTHENIA (Weakness), RASH (Went down to half of the right arm, purple circles after having the rash), VACCINATION SITE RASH (Rash), VACCINATION SITE PRURITUS (Itch) and VACCINATION SITE ERYTHEMA (Pink under the skin). At the time of the report, HEART RATE IRREGULAR (Elevating and fluctuating heartbeat), VACCINATION SITE INFECTION (Got an infection that went down her arm), DIZZINESS (Dizziness), ASTHENIA (Weakness), RASH (Went down to half of the right arm, purple circles after having the rash), VACCINATION SITE RASH (Rash), VACCINATION SITE PRURITUS (Itch) and VACCINATION SITE ERYTHEMA (Pink under the skin) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information included were CEPHALEXIN for the infection and BENADRYL SPRAY for rash and itch
Pt recv vax on 12/8/98; 4 hr post vax pt exp fever, chills, tight throat/ chest; tx=rest, drink fluids, Tylenol
Gave 0.25 ml of dose (booster) instead of 0.5 ml (first shot dose).  Immediately recognized and gave patient the second half of the dose, so that patient received a total dose of 0.5 ml.  No patient harm.